U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06842537) titled 'Study of SYH2062 Injection in Healthy Chinese Volunteers' on Feb. 19.
Brief Summary: The purpose of this study is to evaluate the safety, tolerability, efficacy, pharmacodynamics and pharmacokinetics of SYH2062 injection in healthy Chinese volunteers
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Healthy Chinese Volunteers
Intervention:
DRUG: SYH2062 injection
SYH2062 for sc injection
DRUG: SYH2062-Matching placebo
Normal saline matching volume of SYH2062 doses will be administered
Recruitment Status: NOT_YET_RECRUITING
Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Published by HT Digit...